MRÁZ, Marek. Genetic mechanism for the loss of PRAME in B cell lymphomas. Journal of Clinical Investigation. Ann Arbor: AMER SOC CLINICAL INVESTIGATION INC, 2022, roč. 132, č. 14, s. nestrankovano, 1 s. ISSN 0021-9738. Dostupné z: https://dx.doi.org/10.1172/JCI160983. |
Další formáty:
BibTeX
LaTeX
RIS
@article{2239435, author = {Mráz, Marek}, article_location = {Ann Arbor}, article_number = {14}, doi = {http://dx.doi.org/10.1172/JCI160983}, keywords = {CHRONIC LYMPHOCYTIC-LEUKEMIA22Q11}, language = {eng}, issn = {0021-9738}, journal = {Journal of Clinical Investigation}, title = {Genetic mechanism for the loss of PRAME in B cell lymphomas}, url = {https://www.jci.org/articles/view/160983}, volume = {132}, year = {2022} }
TY - JOUR ID - 2239435 AU - Mráz, Marek PY - 2022 TI - Genetic mechanism for the loss of PRAME in B cell lymphomas JF - Journal of Clinical Investigation VL - 132 IS - 14 SP - nestrankovano EP - nestrankovano PB - AMER SOC CLINICAL INVESTIGATION INC SN - 00219738 KW - CHRONIC LYMPHOCYTIC-LEUKEMIA22Q11 UR - https://www.jci.org/articles/view/160983 N2 - To the Editor: Takata et al. (1) reported that patients with diffuse large B cell lymphoma (DLBCL) relatively frequently (13% of patients) harbor a deletion at the 22q11.22 locus that involves the PRAME gene, and that PRAME loss is associated with poor outcomes and leads to cytotoxic T cell immune escape. The authors comment that “deletions...were located close to the Igλ gene.” I would like to bring to the attention of the authors and readers that the PRAME gene and neighboring ZNF280A, ZNF280B, and GGTLC2 genes are located between variable (V) subgenes for the immunoglobulin lambda (Igλ) light chain (Figure 1). The PRAME deletion is inevitable when a B lymphocyte (normal or malignant) rearranges the Igλ locus and utilizes one of the many V subgenes located more distantly from the J-C region. It is known that approximately 30% to 40% of B lymphocytes express Igλ (~60%–70% express Igκ, since this locus for the Ig light chain is rearranged before Igλ). Therefore, it is not surprising that the loss of PRAME has been previously noted in multiple B cell malignancies, especially chronic lymphocytic leukemia (2–4). Takata et al. (1) observed that patients with PRAME deletions more often have an Igλ rearrangement, but they also report cases of DLBCL with a PRAME deletion and rearranged Igκ. ER -
MRÁZ, Marek. Genetic mechanism for the loss of PRAME in B cell lymphomas. \textit{Journal of Clinical Investigation}. Ann Arbor: AMER SOC CLINICAL INVESTIGATION INC, 2022, roč.~132, č.~14, s.~nestrankovano, 1 s. ISSN~0021-9738. Dostupné z: https://dx.doi.org/10.1172/JCI160983.
|